Navigation Links
Pharmspective Publishes New Assessment of Impact of State Exchanges on Key Insurers and Pharma
Date:8/22/2012

NEW YORK, Aug. 22, 2012 /PRNewswire/ -- Pharmspective, LLC, a market research firm providing syndicated research and knowledge management applications to the pharmaceutical industry, today announced the release of its research report: State Exchanges: Opportunities and Threats for Key Health Insurers/Implications for Pharmaceutical Manufacturers: http://www.pharmspective.com/healthcare-reform-state-exchanges/.

This assessment is a first-of-its kind look into the likely market dynamics resulting from payers' responses to the introduction of State Exchanges and the impact that these responses will have on market access and coverage of pharmaceuticals.

As the pending deadline approaches for states to have functional Insurance Exchanges, key insurers are finalizing their strategic approaches to State Exchange markets.  This week's acquisition of Coventry by Aetna highlights the ongoing positioning and preparation by payers to compete in a post-Affordable Care Act era.  Changes to the market access landscape facing pharmaceutical manufacturers in the U.S. are the foundation for this new Pharmspective research report, which provides a detailed look at the potential impact of State Exchanges on insurers' commercial risk business and the resulting impact on pharmaceutical access and coverage.

Pharmspective's assessment of one of Healthcare Reform's highest impact changes to the U.S. healthcare system discusses:

  • The battleground states where State Exchanges are likely to have the greatest impact and insurer competitive positions and likely intentions in those states
  • Opportunities and threats to market access and coverage of pharmaceuticals, based on assessment of benchmark plans
  • The role of MLRs in potential Payer Exchange contracting aggressiveness
  • Insurer market entry strategies in 'Clearinghouse' states and states where federal government operation of a State Exchange is likely
  • Assessment on non-profit to for-profit conversions among insurers and their impact on the market positions of insurers in key states
  • Customer prioritization of MCO targets for Pharma Managed Markets Teams
  • State Exchange Implications for Contracting and Product Pricing 

"The insights generated by this research will help Pharma Managed Markets Leaders create a blueprint for future State Exchange Strategy Development," stated Stephen Reid, Managing Partner & Co-Founder of Pharmspective.  "Our experience in helping pharma manufacturers move forward with healthcare reform over the past year has allowed us to formulate and address the questions that are critical to understanding in this evolving Market Access landscape."

Pre-orders of the report, scheduled for release on Friday, August 24, can be accessed at the Pharmspective website at http://pharmspective.com.  

About Pharmspective: Pharmspective, LLC, www.pharmspective.com, is a specialty therapeutics market research firm providing commercial insights and knowledge management applications for the biopharmaceutical industry. The company is uniquely focused on understanding the buying process for specialty therapeutics through syndicated market research studies examining clinical decision-making, drug acquisition, access and reimbursement, and patient administration for specialty therapeutics in autoimmune diseases (Rheumatoid Arthritis, Psoriasis, Multiple Sclerosis, Crohn's/UC, and Lupus) and Oncology. Pharmspective's proprietary knowledge management applications create a superior user experience and include the ClearView™ Healthcare Reform app. Follow Pharmspective on twitter.com/Pharmspective. The company maintains offices in New York City and St. Louis, MO.

Contact: Jennifer Strathmann Tel: 314-814-2729 x1002 jennifer.strathmann@pharmspective.com


'/>"/>
SOURCE Pharmspective, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
2. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
3. HemoShear Publishes Key Review on Human-Relevant Organotypic Systems
4. Chronic Heart Failure (CHF) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
5. Masimos Noninvasive Pleth Variability Index as Accurate as Invasive Stroke Volume Variation for Fluid Responsiveness Assessment in Cardiac Surgery
6. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
7. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
8. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
9. First assessment of individual RLS domains in new post-hoc analyses of Neupro® studies
10. EFJohnson Announces Impact Partner Dealer Program
11. Technologies Impacting the Future of Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... , Sept. 8, 2017 Dealmed Medical Supplies, ... supplier of medical equipment, supplies, drugs, vaccines, and specialty ... entered into an agreement to acquire Vantage Medical Supplies, ... in Holtsville, New York . ... supplying new and emerging medical practices, will operate under ...
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), the company commercializing ... Pharma AG to distribute NuvoAir,s spirometry technology to physicians worldwide. ... platform and Novartis, commitment to address the unmet medical needs ... ... "We are ...
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a ... it will host an educational session focused on the ... infection (CLABSI) prevention at the 2017 Annual Scientific Meeting ... will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... CTNext , Connecticut’s ... Awards (EIA), held this past Thursday night at The Space in Hamden. ... their innovative project ideas to a panel of judges for an opportunity to ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... rallying cry to Americans to watch for the discomforts and hidden dangers of ... to senior citizens, everyone is at risk for developing fungal infections on the ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... unveiled the MirixaPro 6.0 platform. As the industry’s leading Medication Therapy Management ... delivered. Based on industry research and market feedback, the latest version of ...
(Date:9/19/2017)... Philadelphia, PA (PRWEB) , ... September 19, 2017 ... ... high-quality orthopedic dog beds, has been officially recognized for its September 2016 donation ... , The company recently received three awards and honors for its contribution ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the lack ... itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. Vitev ... alkaline water technologies, water filtration systems, and consumer education. , ...
Breaking Medicine News(10 mins):